Dotmatics Mini-Summit: From Insights to Impact
The Dotmatics Mini-Summit: From Insights to Impact is a 90-minute digital event featuring CEO Thomas Swalla and experts demonstrating Dotmatics Luma, a no-code, multimodal data platform that automates aggregation of diverse research data from thousands of instruments and software, enables easy data modeling, streamlines scientific workflows, offers upcoming AI-powered natural language search, and supports FAIR data principles, followed by a live Q&A session.
Join us for the Dotmatics Mini-Summit: From Insights to Impact
Join us for an exciting 90-minute digital event where scientists, researchers, and industry experts will gather to learn about and see the latest advancements in R&D technology from Dotmatics.
In this session, our experts, including Thomas Swalla, CEO of Dotmatics, will introduce Dotmatics Luma, a revolutionary multimodal data platform built for scientific discovery. This live demo is perfect for anyone interested in streamlining data management and uncovering new research insights.
Experience the power of Luma first-hand in a live demo:
-
Save Hours by Automating Data Aggregation: Eliminate manual processes by automating the real-time flow of all your research data (regardless of file format) into one powerful data platform. The demo will showcase the near limitless scale of real customer examples ingesting terabytes of data from 1500+ instruments, as well as how Luma aggregates data from key software including GraphPad Prism, Geneious, SnapGene, and more.
-
Easily model your data - no code required: More than data aggregation and storage, Luma is built to easily model data to suit research needs — no code required.
-
Streamline Powerful Workflows: Leverage the power and breadth of Dotmatics’ scientific software in out-of-the-box workflows. The demo will showcase examples of new multimodal workflows for key scientific outcomes including flow cytometry and biologics research.
-
AI-Powered Search: Use Luma's natural language search functionality to ask questions directly about your data and uncover hidden insights (coming soon).
-
Drive FAIR Data Principles: Ensure data continuity and compliance with FAIR principles for long-term collaboration.
Following the live demo, engage directly with our speakers through a dedicated Q&A session to gain insights into the topics discussed or to address any product-related queries you may have.
Featured Speakers
- Thomas Swalla, CEO
- Tamara Adams, Chief Revenue Officer
- Kalim Saliba, Chief Product Officer
- Phil Mounteney, Vice President of Science and Technology
- Matthew Kunicki, CEO/Founder CytIQ, Inc.
Event Details
- 11 June 2024
- On Demand
- VIRTUAL
Related
Data Evolution in Pharma: The Spread of Multimodal
The pharmaceutical industry is shifting from single-mode to multimodal drug discovery, incorporating diverse therapeutic modalities like biologics, gene therapies, and small molecules, but this evolution presents significant challenges in integrating heterogeneous R&D data and technologies, necessitating advanced, compatible platforms to enable efficient collaboration and leverage AI-driven insights for faster, cost-effective drug development.
How Luma Lab Connect Automates Lab Data Acquisition Across 100+ Instruments
Dotmatics Luma Lab Connect, part of the Dotmatics Luma multimodal scientific R&D platform, automates and streamlines the acquisition, management, and preparation of complex, multimodal lab data from over 100 diverse instruments and sources, addressing challenges of data security, integrity, and usability to enhance research productivity and enable FAIR data practices within a unified, low-code SaaS environment.
Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics has launched the Luma Antibody & Protein Engineering Solution, the first in its Luma Multimodal R&D Solutions series, which integrates the Dotmatics Luma Scientific Intelligence Platform with key tools like Geneious, GraphPad Prism, and others to streamline and unify antibody discovery and development—particularly for monoclonal and multispecific antibodies—while supporting a broad range of therapeutic modalities including CAR-T, siRNA, ADCs, CRISPR, and vaccines within a collaborative, multimodal research environment.
The Data Lifecycle: From Instrument Integration to Advanced Analysis
The article discusses how Dotmatics Luma™, a comprehensive scientific data platform, addresses the challenges faced by R&D teams in managing and integrating diverse, multimodal scientific data from instruments and various sources to streamline the entire data lifecycle—from ingestion and processing to advanced analysis—thereby enabling faster, AI-ready insights that accelerate innovation and research outcomes.
3 Customer Trends We’re Watching in 2025
In 2025, life science teams are prioritizing three key trends—Lab-in-a-Loop platforms that integrate instruments, data, workflows, and models to boost R&D efficiency; true multimodal discovery enabled by flexible informatics supporting diverse data types without fragmented tools; and Composite AI leveraging layered, governed, and traceable data across disciplines—all aimed at delivering tangible scientific innovation while addressing resource constraints and stringent AI governance requirements.
Harnessing Data and AI for Scientific R&D
The article explains that successful AI-driven life sciences R&D in 2025 hinges on trusted, well-governed, multimodal data integrated into automated, workflow-embedded AI tools, requiring collaboration between data and scientific intelligence—as exemplified by Dotmatics and Databricks’ partnership enabling low-code scientific apps and flexible workflows to overcome data silos and improve data quality, consistency, and usability for accelerated research.